|
Match
|
Document |
Document Title |
|
|
7303766 |
Coated/treated metal silicate absorbent particles
Coated particles of metal (such as calcium) silicate that exhibit excellent odor neutralization and sebum absorption properties when present within certain cosmetic and/or personal care...
|
|
|
7297689 |
Method for preparing peritoneal dialysate
Carbonyl compounds generated and accumulated in the peritoneal dialysate can be inactivated or eliminated by a carbonyl compound-trapping agent such as aminoguanidine. Carbonyl compounds generated...
|
|
|
7282150 |
Method of extracting and method of purifying an effective substance
A method for extracting a hydrophobic group-containing water-soluble organic compound, comprising the step of bringing an aqueous solution containing the hydrophobic group-containing water-soluble...
|
|
|
7282485 |
Method of obtaining D-glucuronic acid
A method of obtaining D-glucuronic acid. The D-glucuronic acid and its derivatives (lactone, salts, amides, etc.) are biologically high-active compounds, which are widely used in medicine and...
|
|
|
7276485 |
Flowable nondigestible oil and process for making
A flowable nondigestible oil composition having a Consistency in a temperature range of 20° C. to 40° C. of less than about 600 P.sec (n-1) . The flowable nondigestible oil contains a liquid...
|
|
|
7276486 |
Compositions for vaginal treatment
The invention provides mannose phosphate and salts thereof for increasing vaginal cell growth, vaginal cell maturation and vaginal moisture, as well as compositions, articles and methods for...
|
|
|
7276251 |
Sustained-release composition of drugs encapsulated in microparticles of hyaluronic acid
A sustained-release drug composition consisting essentially of microparticles of hyaluronic acid having a high molecular weight or an inorganic salt thereof and a protein or peptide drug encased in...
|
|
|
7273852 |
Synthetic C-glycolipid and its use for treating cancer, infectious diseases and autoimmune diseases
The invention is directed to compounds of formula (I)
wherein X is O or NH; R′ is a hydrocarbon chain; R 3 and R 4 are hydrogen, OH or a monosaccharide; R 5 is hydrogen or a...
|
|
|
7259141 |
Vancomycin analogs and methods thereof
The present invention provides vancomycin analogs and methods related to synthesis of these analogs via chemoenzymatic techniques. In a preferred embodiment, the vancomycin analogs have a...
|
|
|
RE39789 |
Tumor therapy
Neoplasia is treated by administering to a mammalian host a composition comprising ligands for the NKG2D receptor. In addition, other NKG2D ligands, proteins specific for the neoplastic cells and...
|
|
|
7256171 |
Use of core 2 G1cNAc transferase inhibitors in treating inflammation
This invention provides compounds and methods for treating inflammation. The compounds modulate the core 2 oligosaccharide-mediated binding of inflammatory cells, such as neutrophils, to...
|
|
|
7252828 |
Polysaccharide vaccine for staphylococcal infections
The invention relates to compositions of the capsular polysaccharide/adhesin (PS/A) of staphylococci . The PS/A may be isolated or synthesized and includes various modifications to the structure...
|
|
|
7241735 |
Pharmacologically active polypeptide glycoconjugates
The invention relates to glycopeptidic glycoconjugates, in which the polysaccharide is obtained from Candida utilis cells and the peptides are obtained from Ricinus communis seeds. The...
|
|
|
7238529 |
Methods and compositions for treating ocular disorders
The present invention provides a method for treating and/or preventing damage to a retina or optic nerve in a subject comprising administering to the subject a therapeutically effective amount of...
|
|
|
7235263 |
Processes for controlling microbial organic compound production
Processes for preparing products comprising an oxygen-generating additive for reducing the amount of skin irritation and inflamation and odor are disclosed. Specifically, products such as training...
|
|
|
RE39705 |
Method of treating glutathione deficient mammals
Glutathione (GSH) is a tripeptide of extreme importance as a catalyst, reductan, and reactant. It can be depleted intra-cellularly either by forming a direct complex with an electrophilic agent...
|
|
|
7217698 |
Use of mannosamine derivatives for the stimulation of neurite growth
The present invention relates to the use of peracylated N-acyl-mannosamine derivatives for the preparation of a medicament for stimulating neurite growth.
|
|
|
7217696 |
Glycuronamides, glycosides and orthoester glycosides of fluoxetine, analogs and uses thereof
Disclosed are glycosides, orthoester glycosides and glycuronamides of fluoxetine and analogs thereof to treat conditions and diseases such as depression.
|
|
|
7202219 |
Use of D-tagatose as a prebiotic food component
Oral intake of D-tagatose in a prebiotic food induces production of butyrate and stimulates the growth of beneficial bacteria in the human colon. Therefore it is believed to be useful in food or...
|
|
|
7198796 |
Antifungal parenteral products
Parenteral pharmaceutical formulations containing an echinocandin antifungal compound and an aqueous solvent are provided, wherein the formulation includes ethanol, for example about 20% w/v...
|
|
|
7196058 |
Method of treatment of conditions by administration of streptolysin O
Method for administering streptolysin O for treatment of various conditions including connective tissue disorders, reproductive fibroses and conditions mediated by the CD44 receptor. The invention...
|
|
|
7192914 |
Prevention of atherosclerosis and undesired blood clotting by reducing von Willebrand factor
This invention provides methods and compositions for treating and preventing atherosclerosis other undesired blood clotting. The methods for treating and preventing atherosclerosis and related...
|
|
|
7189351 |
D-tagatose as an anti-biofilm agent
There is disclosed a method for disrupting biofilm and for inhibiting biofilm formation in an aqueous environment that comprises contacting said environment with an effective amount of D-tagatose.
|
|
|
7189683 |
Non-ionic surfactants based upon alkyl polyglucoside
The invention relates to a series of polyglycoside derivatives that contain water-soluble groups introduced into the molecule by reaction with the hydroxyl groups present in the starting...
|
|
|
7186696 |
Reagent and method for measuring amylase
An object of the present invention is to provide a means for the measurement of amylase activity that exists in a biological sample such as saliva in a more convenient manner and particularly to...
|
|
|
7183261 |
Galactosylceramide analogs, and β-glucocerebrosidase activators, external skin preparations and method of activating β-glucocerebrosidase using the analogs
Galactosylceramide analogues represented by the following formula (1) or (2).
(wherein X and Y each represent S or O, R 1 and R 2 each represent an alkyl group or an alkenyl group each having...
|
|
|
7183266 |
Dual induced viscosity fiber system and uses thereof
The present invention relates generally to a method of blunting the postprandial glycemic response to a meal by feeding a dual induced viscosity fiber system. The first component of the induced...
|
|
|
7182939 |
Hair tonic composition
A hair tonic composition containing adenosine, adenosine 5′-phosphate, and/or an adenosine 5′-phosphate salt as an active ingredient.
|
|
|
7179792 |
Combination product of a 1,4-benzothiepine 1,1-dioxide compound with at least one other active ingredient and the use of the product
The present invention is directed to a 1,4-benzothiepine 1,1-dioxide compound of formula I
in which the radicals have the meanings defined herein, or a pharmaceutically acceptable salt or...
|
|
|
7169392 |
Neisseria meningitidis serogroup B glycoconjugates and methods of producing the same
The present invention pertains generally to novel Neisseria meningitidis serogroup B glycoconjugates. More particularly, the invention pertains to glycoconjugates formed from a Neisseria...
|
|
|
7169761 |
Azulene derivatives and salts thereof
The present invention provides an azulene derivative and a salt thereof, wherein an azulene ring is bonded to a benzene ring directly or via a lower alkylene which may be substituted with a halogen...
|
|
|
7166582 |
Antiallergic composition
The present invention provides a sate and excellent antiallergic composition, and more particularly a preventive and therapeutic composition for atopic dermatitis, including an antiallergic...
|
|
|
7163703 |
Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds
The invention relates to the use of arsenic compounds to treat a variety of neoplastic diseases. The present invention encompasses the administration to a mammal of arsenic in the form of a salt,...
|
|
|
7160865 |
Cancer treatment including glycolytic inhibitors
Glycolytic inhibitors are useful in the treatment of solid tumors by attacking anaerobic cells at the center on the tumor. 2-deoxyglucose, oxamate and various analogs thereof are identified as...
|
|
|
7160552 |
Method of feeding a ruminant
A method of feeding ruminants, the method including feeding a ruminant a fluid animal feed during a feeding period, the fluid animal feed including an animal feed component and the ruminant...
|
|
|
7157431 |
Compositions of plant carbohydrates as dietary supplements
Compositions of plant carbohydrates for dietary supplements and nutritional support for promotion and maintenance of good health. Defined nutritionally effective amounts of one to eleven essential...
|
|
|
7157078 |
Devices and methods for eliminating termite colonies
This invention relates to devices, kits, and methods for eliminating termite colonies. The kits, devices, and methods employ a termiticidal bait matrix containing
a) a termiticide selected...
|
|
|
7153492 |
Effervescent solid composition of matter
An effervescent solid composition of matter is provided, which comprises, as an active component, a substance selected from chitosan, its derivatives and salts thereof and a second component...
|
|
|
7153877 |
Method and composition for preventing or reducing the symptoms of insulin resistance syndrome
A method for preventing and or reducing the symptoms of insulin resistance and a related syndrome in persons comprises identifying persons having or at risk for having such symptoms, and...
|
|
|
7153837 |
Agent for protection of retinal neurons
This invention relates to an agent for the protection of retinal neurons which comprises, as an effective ingredient, sulfamate derivative having the following formula:
and to a method for the...
|
|
|
RE39433 |
Therapeutic agents as cytokine antagonists and agonists
A therapeutic agent capable of of binding to the F′-G′ loop of domain 4 of the common c Chain of the receptor for GM-CSF, IL-3, and IL-5. The amino acid Tyr 421 which is located in the...
|
|
|
7144696 |
Use of azetidinone compounds
The use of azetidinone compounds that are inhibitors of cholesterol absorption as tools for discovering and characterizing proteins involved in trafficking or absorption of cholesterol and/or...
|
|
|
7141605 |
Method of controlling animal pests and disinfecting inanimate surfaces
A method of treating plant and animal systems and inanimate surfaces for the purposes of controlling plant pests, introducing pesticides and nutrients into plants, mitigating frost damage to...
|
|
|
7141554 |
Method of treating irritable bowel syndrome
A nutritional composition is disclosed which comprises synergistic functional carbohydrates for preventing or treating infection by pathogenic bacteria and/or promoting gut flora balance and...
|
|
|
7132415 |
Methods and therapeutic combinations for the treatment of xanthoma using sterol absorption inhibitors
The present invention provides therapeutic combinations and methods including at least one sterol or 5α-stanol absorption inhibitor that can be useful for treating xanthomas.
|
|
|
7129220 |
Substituted indole-O-glucosides
Substituted indole-O-glucosides, compositions containing them, and methods of using them, for example for the treatment of diabetes and Syndrome X are disclosed.
|
|
|
7129217 |
Aqueous acrylamide solution containing saccharide
This invention provides an aqueous solution of acrylamide that is useful as a starting material for high-quality polyacrylamide. Starting materials for polyacrylamide are an aqueous solution of...
|
|
|
7129219 |
Immunoeffector compounds
This invention provides compounds containing a 2-deoxy-2-amino-β-D-glucopyranose (glucosamine) glycosidically linked to a cyclic aminoalkyl (aglycon) group. The invention further provides methods...
|
|
|
7125853 |
Bicyclic carbohydrate compounds useful in the treatment of infections caused by Flaviviridae sp., such as hepatitis C and bovine viral diarrhea viruses
We describe the use of bicyclic carbohydrates for the treatment of hepatitis C virus infections. Different bicyclic carbohydrates were tested in vitro against DNA-viruses, retro-viruses and ...
|
|
|
7125852 |
Geranyl compounds
This invention provides compounds having excellent antitumor activity, which are represented by the following formulae
in which R 1 , R 2 , R 3 , m, n and R 4 have the significations as given...
|